A screen shot of a Loop control panel and a women researcher with computer imagery

“I think it’s just the beginning” – A new way to test DIY pump systems from UVA

Researchers at UVA recently published a study called Design and Validation of an Open-Source Closed-Loop Testbed for Artificial Pancreas Systems. They say what they’ve set up here is quote – a valid tool that can be used by the research community to demonstrate the effectiveness of different control algorithms and safety features for APS, automated…

Sarah Kaminer Bourland and Patients for Affordable Drugs logo

“We’ve finally opened that door” – What Medicare negotiations will mean for people with diabetes

You may know the Inflation Reduction Act best for being the latest time an insulin price measure was NOT voted through. But supporters say there’s a lot here that will help patients save money, including those with diabetes. We talk with Sarah Kaminer Bourland, Legislative Director of Patient for Affordable Drugs Now. She explains what…

Sernova CEO Philip Toleikis

“This is Becoming a Reality” – Sernova’s Cell Therapy Approach to a Functional T1D Cure

Big news from Sernova, one of the companies hoping that implantable stem cells will be a functional cure for diabetes. They recently announced that the first person in their trials with type 1 is completely off injected or infused insulin – and is making their own. Stacey talks to Dr. Philip Toleikis, Sernova’s president and…

Stacey and Kevin Sayer on Zoom. Kevin holds up a box with G7 on the side

“Dexcom is Preparing for the Future” CEO Kevin Sayer on G7, the international market, competitors and more

Dexcom CEO Kevin Sayer joins Stacey from the American Diabetes Association’s Scientific Sessions with new G7 information, a response to Abbott’s Libre 3 approval, addressing rumors about acquiring another diabetes company and a lot more. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care…